 |
|
Preventive Services Guidelines for Primary Care Clinicians Caring for Adults and Adolescents Infected With the Human Immunodeficiency Virus
A. Russell Gerber, MD;
Ronald O. Valdiserri, MD, MPH;
David R. Holtgrave, PhD;
T. Stephen Jones, MD;
Gary R. West, MPA;
Alan R. Hinman, MD, MPH;
James W. Curran, MD, MPH
Arch Fam Med. 1993;2(9):969-979.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Drotman DP. Earlier diagnosis of human immunodeficiency virus (HIV) infection and more counseling. Ann Intern Med. 1989;110:680-681.
FREE FULL TEXT
2. Centers for Disease Control and Prevention. Strategic Plan for Preventing Human Immunodeficiency Virus (HIV) Infection. Atlanta, Ga: US Dept of Health and Human Services, Public Health Service; 1992. DHHS publication HIV/ODD(HIV)/6-92/026. 3. Gerbert B, Maguire BT, Bleecker T, Coates TJ, McPhee SJ. Primary care physicians and AIDS: attitudinal and structural barriers to care. JAMA. 1991;266:2837-2842.
FREE FULL TEXT
4. Centers for Disease Control. Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. MMWR Morb Mortal Wkly Rep. 1987;36:509-515.
PUBMED
5. Centers for Disease Control and Prevention. Cooperative agreements for human immunodeficiency virus (HIV): prevention projects program announcement and availability of funds for fiscal year 1993. Federal Register. September 4, 1992;57:40675-40683.
6. US Preventive Services Task Force. Guide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 Interventions. Baltimore, Md: Williams & Wilkins; 1989. 7. Kassler WJ, Wu AW. Addressing HIV infection in office practice: assessing risk, counseling, and testing. Prim Care. 1992;19:19-33.
PUBMED
8. Lewis CE, Freeman HE. The sexual history-taking and counseling practices of primary care physicians. West J Med. 1987;147:165-167.
PUBMED
9. Lewis CE, Montgomery K. The AIDS-related experiences and practices of primary care physicians in Los Angeles: 1984-89. Am J Public Health. 1990;80:1511-1513.
FREE FULL TEXT
10. Boekeloo BO, Marx ES, Kral AH, Coughlin SC, Bowman M, Rabin DL. Frequency and thoroughness of STD/HIV risk assessment by physicians in a high-risk metropolitan area. Am J Public Health. 1991;81:1645-1648.
FREE FULL TEXT
11. Chiasson MA, Stoneburner RL, Hildebrandt DS, Ewing WE, Telzak EE, Jaffe HW. Heterosexual transmission of HIV-1 associated with the use of smokable freebase cocaine (crack). AIDS. 1991;5:1121-1126.
PUBMED
12. Centers for Disease Control. Relationship of syphilis to drug use and prostitution^Connecticut and Philadelphia, Pennsylvania. MMWR Morb Mortal Wkly Rep. 1988;37:755-758, 764.
PUBMED
13. Bayer R, Toomey KE. HIV prevention and the two faces of partner notification. Am J Public Health. 1992;82:1158-1164.
FREE FULL TEXT
14. Hardy AM, Dawson DA. HIV antibody testing among adults in the United States: data from 1988 NHIS. Am J Public Health. 1990;801:586-589.
15. Valdiserri RO, Holtgrave DR, Brackbill RM. American adults' knowledge of HIV testing availability. Am J Public Health. 1993;83:525-528.
FREE FULL TEXT
16. Centers for Disease Control and Prevention. Technical guidance on HIV counseling. MMWR Morb Mortal Wkly Rep. 1993;42(No. RR-2):8-17.
17. Davis H, Fallowfield L, eds. Counselling and Communication in Health Care. New York, NY: John Wiley & Sons Inc; 1991. 18. Catania JA, Kegeles SM, Coates TJ. Towards an understanding of risk behavior: an AIDS risk reduction model (ARRM). Health Educ Q. 1990;17:53-72.
PUBMED
19. Weinstein ND, Sandman PM. A model of the precaution adoption process: evidence from home radon testing. Health Psychol. 1992;11:170-180.
PUBMED
20. Prochaska JO, Di Clemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol. 1983;51:390-395.
PUBMED
21. Prochaska JO, Di Clemente CC, Norcross JC. In search of how people change: applications to addictive behaviors. Am Psychol. 1992;47:1102-1114.
PUBMED
22. Higgins DL, Galavotti C, O'Reilly KR, et al. Evidence for the effects of HIV antibody counseling and testing on risk behaviors. JAMA. 1991;266:2419-2429.
FREE FULL TEXT
23. Centers for Disease Control. Patterns of sexual behavior change among homosexual/bisexual men^selected US sites, 1987-1990. MMWR Morb Mortal Wkly Rep. 1991;40:792-794.
PUBMED
24. Kelly JA, St Lawrence JS, Diaz YE, et al. HIV risk behavior reduction following intervention with key opinion leaders of population: an experimental analysis. Am J Public Health. 1991;81:168-171.
FREE FULL TEXT
25. Sloand EM, Pitt E, Chiarello RJ, Nemo GJ. HIV testing: state of the art. JAMA. 1991;266:2861-2866.
FREE FULL TEXT
26. Committee on Human Retrovirus Testing, Association of State and Territorial Public Health Laboratory Directors. Fifth Consensus Conference on Testing for Human Retroviruses: Report and Recommendations. Kansas City, Mo; March 6-8, 1990. 27. Rogers MF, Ou CY, Kilbourne B, Schochetman G. Advances and problems in the diagnosis of HIV infection in infants. In: Pizzo PA, Wilfert CM, eds. Pediatric AIDS: The Challenge of HIV Infection in Infants, Children and Adolescents. Baltimore, Md: Williams & Wilkins; 1990:159-174. 28. McDougal JS, Kennedy MS, Sligh JM, Cort SP, Mawle A, Nicholson JKA. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. Science. 1985;231:382-385.
29. Bowen DL, Lane HC, Fauci AS. Immunopathogenesis of the acquired immunodeficiency syndrome. Ann Intern Med. 1985;103:704-709.
FREE FULL TEXT
30. Fauci AS. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science. 1988;239:617-622.
FREE FULL TEXT
31. Brinchmann JE, Vartdal F, Thorsby E. T lymphocyte subset changes in human immunodeficiency virus infection. J Acquir Immune Defic Syndr. 1989;2:398-403.
PUBMED
32. Ammann AJ, Abrams D, Conant M, et al. Acquired immune dysfunction in homosexual men: immunologic profiles. Clin Immunol Immunopathol. 1983;27:315-325.
PUBMED
33. Goedert JJ, Biggar RJ, Melbye M, et al. Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus. JAMA. 1987;257:331-334.
FREE FULL TEXT
34. Polk BF, Fox R, Brookmeyer R, et al. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med. 1987;316:61-66.
ABSTRACT
35. Detels R, English PA, Giorgi JV, et al. Patterns of CD4+ cell changes after HIV-1 infection indicate the existence of a codeterminant of AIDS. J Acquir Immune Defic Syndr. 1988;1:390-395.
PUBMED
36. Munoz A, Carey V, Saah AJ, et al. Predictors of decline in CD4 lymphocytes in a cohort of homosexual men infected with human immunodeficiency virus. J Acquir Immune Defic Syndr. 1988;1:396-404.
PUBMED
37. Lang W, Perkins H, Anderson RE, Royce R, Jewell N, Winkelstein W. Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. J Acquir Immune Defic Syndr. 1989;2:63-69.
PUBMED
38. Centers for Disease Control and Prevention. Guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus infection. MMWR Morb Mortal Wkly Rep. 1992;41(No. RR-8):1-17.
PUBMED
39. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep. 1992;41(No. RR-17):1-19.
PUBMED
40. Fahey JL, Taylor JMG, Detels R, et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med. 1990;322:166-172.
ABSTRACT
41. Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep. 1989;38(No. S-5):1-9.
PUBMED
42. Centers for Disease Control. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep. 1992;41(No. RR-4):1-11.
PUBMED
43. Volberding PA, Lagakos SW, Koch MA, et al. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med. 1990;322:941-949.
ABSTRACT
44. National Institutes of Health. State-of-the-art conference on azidothymidine therapy for early HIV infection. Am J Med. 1990;89:335-344.
PUBMED
45. Cotton P. Surrogate markers of disease studied as means of determining AIDS drugs' effectiveness. JAMA. 1990;264:2362, 2365.
FREE FULL TEXT
46. Fauci AS. ddl: a good start, but still phase I. N Engl J Med. 1990;322:1386-1388.
PUBMED
47. Lambert JS, Seidlin M, Reichman RC, et al. 2',3'-dideoxyinosine (ddl) in patients with the acquired immunodeficiency syndrome or AIDS-related complex: a phase I trial. N Engl J Med. 1990;322:1333-1340.
ABSTRACT
48. Cooley TP, Kunches LM, Saunders CA, et al. Once-daily administration of 2',3'-dideoxyinosine (ddl) in patients with the acquired immunodeficiency syndrome or AIDS-related complex: results of a phase I trial. N Engl J Med. 1990;322:1340-1345.
ABSTRACT
49. Butler KM, Husson RN, Balis FM, et al. Dideoxyinosine in children with symptomatic human immunodeficiency virus infection. N Engl J Med. 1991;324:137-144.
ABSTRACT
50. Taylor JMG, Fahey JL, Detels R, Giorgi JV. CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. J Acquir Immune Defic Syndr. 1989;2:114-124.
PUBMED
51. Kessler HA, Landay A, Pottage JC, Benson CA. Absolute number versus percentage of T-helper lymphocytes in human immunodeficiency virus infection. J Infect Dis. 1990;161:356-357.
PUBMED
52. Centers for Disease Control. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in healthcare settings. MMWR Morb Mortal Wkly Rep. 1988;37:377-382, 387-388.
PUBMED
53. Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep. 1991;40(No. RR-2):1-13.
PUBMED
54. Fischl MA, Dickinson GM, La Voie L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis cariniipneumonia in AIDS. JAMA. 1988;259:1185-1189.
FREE FULL TEXT
55. Hirschel B, Lazzarin A, Chopard P, et al. A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N Engl J Med. 1991;324:1079-1083.
ABSTRACT
56. Castellano AR, Nettleman MD. Cost and benefit of secondary prophylaxis for Pneumocystis carinii pneumonia. JAMA. 1991;266:820-824.
FREE FULL TEXT
57. Graham NMH, Zeger SL, Park LP, et al. The effects on survival of early treatment of human immunodeficiency virus infection. N Engl J Med. 1992;326:1037-1042.
ABSTRACT
58. Anderson DJ, O'Brien TR, Politch JA, et al. Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen. JAMA. 1992;267:2769-2774.
FREE FULL TEXT
59. Chirianni A, Perna E, Liuzzi G, et al. Absence of anti-HIV seroconversion in heterosexual partners of HIV patients treated with zidovudine. In: Program and Abstracts of the VIII International Conference on AIDS/III STD World Congress; July 19-24, 1992; Amsterdam, the Netherlands. Abstract PoC 4530:333. 60. Drugs for AIDS and associated infections. In: Abramowicz M, ed. Med Letter. 1991;33:95-102.
61. Larder BA, Darby G, Richman DD. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science. 1989;243:1731-1734.
FREE FULL TEXT
62. Nightingale SL. Didanosine (ddl) approved for advanced HIV infection. JAMA. 1991;266:2528.
FREE FULL TEXT
63. Nightingale SL. Zalcitabine approved for use in combination with zidovudine for HIV infection. JAMA. 1992;268:705.
FREE FULL TEXT
64. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989;320:545-550.
ABSTRACT
65. Di Perri G, Cruciani M, Danzi MC, et al. Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet. 1989;2:1502-1504.
PUBMED
66. Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons^Florida and New York, 1988-1991. MMWR Morb Mortal Wkly Rep. 1991;40:585-591.
PUBMED
67. Centers for Disease Control. Tuberculosis outbreak among persons in a residential facility for HIV-infected persons^San Francisco. MMWR Morb Mortal Wkly Rep. 1991;40:649-652.
PUBMED
68. Daley CL, Small PM, Schecter GF, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus: an analysis using restriction-fragment-length polymorphisms. N Engl J Med. 1992;326:231-235.
ABSTRACT
69. Dooley SW, Villarino ME, Lawrence M, et al. Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients. JAMA. 1992;267:2632-2634.
FREE FULL TEXT
70. Centers for Disease Control. Tuberculosis and human immunodeficiency virus infection: recommendations of the Advisory Committee for the Elimination of Tuberculosis (ACET). MMWR Morb Mortal Wkly Rep. 1989;38:236-238, 243-250.
PUBMED
71. Centers for Disease Control. Screening for tuberculosis and tuberculous infection in high-risk populations: recommendations of the Advisory Committee for Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep. 1990;39(No. RR-8):1-7.
PUBMED
72. Centers for Disease Control. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR Morb Mortal Wkly Rep. 1991;40(No. RR-5):27-33.
73. Selwyn PA, Sckell BM, Alcabes P, Friedland GH, Klein RS, Schoenbaum EE. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA. 1992;268:504-509.
FREE FULL TEXT
74. Centers for Disease Control and Prevention. Management of persons exposed to multidrugresistant tuberculosis. MMWR Morb Mortal Wkly Rep. 1992;41(No. RR-11):59-71.
75. Centers for Disease Control. Update on adult immunization: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep. 1991;40(No. RR-12):1-94.
PUBMED
76. Wasserheit JN. Epidemiological synergy: interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis. 1992;19:61-77.
PUBMED
77. Mertens TE, Hayes RJ, Smith PG. Epidemiological methods to study the interaction between HIV infection and other sexually transmitted diseases. AIDS. 1990;4:57-65.
PUBMED
78. Greenblatt RM, Lukehart SA, Plummer FA, et al. Genital ulcerations as a risk factor for human immunodeficiency virus infection. AIDS. 1988;2:47-50.
PUBMED
79. Centers for Disease Control. 1989 Sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep. 1989;38(No. S-8):1-43.
PUBMED
80. Quinn TC, Glasser D, Cannon RO, et al. Human immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases. N Engl J Med. 1988;318:197-203.
ABSTRACT
81. Quinn TC, Cannon RO, Glasser D, et al. The association of syphilis with risk of human immunodeficiency virus infection in patients attending sexually transmitted disease clinics. Arch Intern Med. 1990;150:1297-1302.
FREE FULL TEXT
82. Simonsen JN, Cameron DW, Gakinya MN, et al. Human immunodeficiency virus infection among men with sexually transmitted diseases: experience from a center in Africa. N Engl J Med. 1988;319:274-278.
ABSTRACT
83. Holmberg SD, Stewart JA, Gerber AR, et al. Prior herpes simples virus type 2 infection as a risk factor for HIV infection. JAMA. 1988;259:1048-1050.
FREE FULL TEXT
84. Laga M, Nzila N, Manoka AT, et al. Non ulcerative sexually transmitted diseases (STD) as risk factors for HIV infection. In: Program and Abstracts of the Sixth International Conference on AIDS; June 20-24, 1990; San Francisco, Calif. Abstract Th.C.97:158. 85. Centers for Disease Control. Risk for cervical disease in HIV-infected women^New York City. MMWR Morb Mortal Wkly Rep. 1990;39:846-849.
PUBMED
86. Imam N, Carpenter CCJ, Mayer KH, Fisher A, Stein M, Danforth SB. Hierarchical pattern of mucosal candida infections in HIV-seropositive women. Am J Med. 1990;89:142-146.
PUBMED
87. Hoegsberg B, Abulafia O, Sedlis A, et al. Sexually transmitted diseases and human immunodeficiency virus infection among women with pelvic inflammatory disease. Am J Obstet Gynecol. 1990;163:1135-1139.
PUBMED
88. Italian Multicentre Study. Epidemiology, clinical features, and prognostic factors of paediatric HIV infection. Lancet. 1988;2:1043-1046.
PUBMED
89. Ryder RW, Nsa W, Hassig SE, et al. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. N Engl J Med. 1989;320:1637-1642.
ABSTRACT
90. Blanche S, Rouzioux C, Moscato MG, et al. A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. N Engl J Med. 1989;320:1643-1648.
ABSTRACT
91. European Collaborative Study. Children born to women with HIV-1 infection: natural history and risk of transmission. Lancet. 1991;337:253-260.
PUBMED
92. Centers for Disease Control. Recommendations for assisting in the prevention of perinatal transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus and acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep. 1985;34:721-726, 731-732.
PUBMED
93. Sunderland A. Influence of human immunodeficiency virus infection on reproductive decisions. Obstet Gynecol Clin North Am. 1990;17:585-594.
PUBMED
94. Selwyn PA, Carter RJ, Schoenbaum EE, Robertson VJ, Klein RS, Rogers MF. Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users. JAMA. 1989;261:3567-3571.
FREE FULL TEXT
95. Genetic counseling. In: Behrman RE, Vaughan VC, eds. Nelson Textbook of Pediatrics. 12th ed. Philadelphia, Pa: WB Saunders Co; 1983:312-315. 96. Van de Perre P, Simonon A, Msellati P, et al. Postnatal transmission of human immunodeficiency virus type 1 from mother to infant: a prospective cohort study in Kigali, Rwanda. N Engl J Med. 1991;325:593-598.
ABSTRACT
97. European Collaborative Study. Risk factors for mother-to-child transmission of HIV-1. Lancet. 1991;339:1007-1012.
98. Dunn DT, Newell ML, Ades AE, Peckham CS. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet. 1992;340:585-588.
PUBMED
99. World Health Organization. Consensus Statement from the WHO/UNICEF Consultation on HIV Transmission and Breast-feeding. Geneva, Switzerland: World Health Organization; May 1992. 100. Payne FJ, Sharrett CS, Poretz DN, et al. Community-based case management of HIV disease. Am J Public Health. 1992;82:893-894.
PUBMED
101. Morrison C. Case management and the determination of appropriate care settings for persons living with AIDS. In: AHCPR Conference Proceedings: Community-Based Care of Persons With AIDS: Developing a Research Agenda. Minneapolis, Minn: US Dept of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; April 1990; 75-82. 102. Benjamin AE. Long-term care and AIDS: perspectives from experience with the elderly. Milbank Q. 1988;66:415-443.
PUBMED
103. Centers for Disease Control. Public health uses of HIV-infection reports^South Carolina, 1986-1991. MMWR Morb Mortal Wkly Rep. 1992;41:245-249.
104. Public Health Service. Healthy People 2000: National Health Promotion and Disease Prevention Objectives: Full Report, With Commentary. Washington, DC: US Dept of Health and Human Services, Public Health Service; 1991. DHHS publication PHS 91-50212.
|
